Galapagos appoints Paul Stoffels as Chief Executive Officer

    NEXT STORY
    Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
    PREV STORY
    Alberta Innovates invests in research to tackle growing threat of chronic wasting disease
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Terveystalo Plc: Terveystalo Group Financial Statements Bulletin 2018

    Terveystalo Plc Stock Exchange Release 14 February 2019 at 9:00 EET Record year, strong ...

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration

    SILVER SPRING, Md., March 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB: PMCB), ...

    author_avatar
    NASDAQ Market News

    IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union

    IMRALDITM is approved in the European Union for the same 14 complex autoimmune conditions ...

    author_avatar
    NASDAQ Market News